September 2018
Vol 6 | Issue 203

Q&A with Orrin Ailloni-Charas and R. Jens Francis

MD, MBA, Founder, Managing Partner and Founder, Managing Partner of Hermes Life Sciences Ventures

Principle Series:

Principle Series:

Family Office Insights sits down with Orrin Ailloni-Charas & R. Jens Francis to discuss Hermes Life Science Ventures, their new venture fund opportunity in the dynamic early-stage health care space.  It was founded by experienced managers from the investing platform, AngelMD.  Hermes LSV is seeking Limited Partners to provide up to $50 million in capital. Through its extensive existing relationships in the early-stage health care space, Hermes LSV already is prepared to deploy capital towards thoroughly vetted companies.

Please join Family Office Insights for this gathering on Thursday, Sept 27th, 2018 to learn more about Hermes Life Science Ventures.

Family Office Insights

PRESENTS: Hermes Life Sciences Ventures


Family Office Insights is a voluntary, “opt-in” collaborative peer-to-peer community of single family offices, qualified investors and institutional investors. Join the community here www.familyofficeinsights.com



Orrin Ailloni-Charas and R. Jens Francis

Orrin Ailloni-Charas, MD, MBA

Dr. Orrin Ailloni-Charas is an honors graduate of the University of Pennsylvania, earned his MD at the NYU School of Medicine, and earned his MBA from Columbia University. He completed his residency as a specialist in anesthesia at the Mount Sinai Hospital in New York City. He is a Board Certified Anesthesiologist and served from 2003-2016 as the Chief Financial Officer of a large private anesthesia practice in San Francisco. He also has held several consulting positions with digital health and biopharma companies He is the Vice President Of Clinical Investment Operations and Investment Advisor to the Catalyst Fund at AngelMD and played an integral role in developing the processes involved around syndicate investing and the mechanics and metrics involved in the quantitative analytics AngelMD relies on to identify top performing healthcare startups.

Dr. Ailloni-Charas is a founder and Managing Partner of Hermes Life Science Ventures. Along with his co-founder, Jens Francis, Dr. Ailloni-Charas will draw on his experience of 25 years in the clinical practice of anesthesia as well as lessons learned from his time at AngelMD to maximize the potential for significant returns for the Limited Partners in Hermes Fund I.

R. Jens Francis

Mr. Francis is a 25-year veteran of Silicon Valley, building and operating companies in healthcare, technology and financial services. He began his career as a technology executive leading teams that worked on deep data analytics for some of Silicon Valley’s biggest names including KLA-Tencor Instruments, National Semiconductor and Pivotal.

An expert in technology-driven financial markets, Mr. Francis has built online trading systems for foreign exchange, highly liquid financial instruments and carbon trading. In 2014, he used that expertise to build angelMD, the world’s largest investment marketplace of early-stage life sciences companies qualified by physicians. In 2016, Mr. Francis pivoted to run the investment arm of angelMD where he and Dr. Ailloni-Charas have overseen the selection of and diligence on 37 companies that are creating products in the fields of biopharma, medical device and digital health.

Prior to founding angelMD, Mr. Francis was an operating executive at Accretive, LLC a multi-billion-dollar private equity firm. Their team focused on building best-of-class businesses by partnering with some of the nation’s leading health systems.